Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-05 3:36 pm Sale | 2024-11-30 | 13G | Cabaletta Bio, Inc. CABA | Jennison Associates LLC | 2,512,053 5.100% | -2,658,182 (-51.41%) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | Venrock Healthcare Capital Partners III, L.P. | 1,590,696 3.300% | -973,256 (-37.96%) | Filing History |
| 2024-11-14 4:02 pm Purchase | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | Alger Associates, Inc. | 4,119,394 8.400% | 792,993 (+23.84%) | Filing History |
| 2024-11-14 1:28 pm Purchase | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | T. Rowe Price Investment Management, Inc. | 3,673,724 7.500% | 3,673,724 (New Position) | Filing History |
| 2024-11-12 1:25 pm Unchanged | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | The Vanguard Group | 2,553,710 5.220% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:34 am Purchase | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | Adage Capital Management, L.P. | 3,634,475 7.430% | 3,634,475 (New Position) | Filing History |
| 2024-11-04 12:01 pm Unchanged | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | The Vanguard Group | 2,553,710 5.220% | 0 (Unchanged) | Filing History |
| 2024-11-04 11:38 am Unchanged | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | The Vanguard Group | 2,553,710 5.220% | 0 (Unchanged) | Filing History |
| 2024-11-04 11:38 am Purchase | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | The Vanguard Group | 2,553,710 5.220% | 2,553,710 (New Position) | Filing History |
| 2024-10-17 12:00 pm Sale | 2024-09-30 | 13G | Cabaletta Bio, Inc. CABA | STATE STREET CORP STT | 896,123 1.800% | -1,698,347 (-65.46%) | Filing History |
| 2024-08-22 6:10 pm Purchase | 2024-08-12 | 13G | Cabaletta Bio, Inc. CABA | Bain Capital Life Sciences Opportunities III, LP | 2,760,888 5.700% | 760,888 (+38.04%) | Filing History |
| 2024-06-10 4:59 pm Purchase | 2024-06-10 | 13G | Cabaletta Bio, Inc. CABA | PRUDENTIAL FINANCIAL INC PRU | 5,655,720 12.080% | 5,655,720 (New Position) | Filing History |
| 2024-06-06 1:01 pm Purchase | 2024-05-31 | 13G | Cabaletta Bio, Inc. CABA | Jennison Associates LLC | 5,170,235 11.100% | 5,170,235 (New Position) | Filing History |
| 2024-02-14 8:53 pm Purchase | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Venrock Healthcare Capital Partners III, L.P. | 2,563,952 6.400% | 668,667 (+35.28%) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Baker Bros. Advisors LP | 1,457,626 3.400% | 113,626 (+8.45%) | Filing History |
| 2024-02-14 4:11 pm Sale | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Alger Associates, Inc. | 3,326,401 7.800% | -152,026 (-4.37%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Commodore Capital LP | 1,900,000 4.400% | 441,633 (+30.28%) | Filing History |
| 2024-02-14 3:01 pm Sale | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Cormorant Asset Management, LP | 0 0.000% | -1,971,739 (Position Closed) | Filing History |
| 2024-02-14 09:20 am Purchase | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Lynx1 Capital Management LP | 2,139,644 4.990% | 2,139,644 (New Position) | Filing History |
| 2024-02-13 6:47 pm Unchanged | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Bain Capital Life Sciences Opportunities III, LP | 2,000,000 4.700% | 0 (Unchanged) | Filing History |